Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota
Nutrients · 2024
DOI: 10.3390/nu16081164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Deyu Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin 150030, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Escherichia coli O157, Probiotics, Escherichia coli Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Enterohemorrhagic Escherichia coli (EHEC) serotype O157:H7 is a commonly encountered foodborne pathogen that can cause hemorrhagic enteritis and lead to hemolytic uremic syndrome (HUS) in severe cases. Bifidobacterium is a beneficial bacterium that naturally exists in the human gut and plays a vital role in maintaining a healthy balance in the gut microbiota. This study investigated the protective effects of B. longum K5 in a mouse model of EHEC O157:H7 infection. The results indicated that pretreatment with B. longum K5 mitigated the clinical symptoms of EHEC O157:H7 infection and attenuated the increase in myeloperoxidase (MPO) activity in the colon of the mice. In comparison to the model group, elevated serum D-lactic acid concentrations and diamine oxidase (DAO) levels were prevented in the K5-EHEC group of mice. The reduced mRNA expression of tight junction proteins (ZO-1, Occludin, and Claudin-1) and mucin MUC2, as well as the elevated expression of virulence factors Stx1A and Stx2A, was alleviated in the colon of both the K5-PBS and K5-EHEC groups. Additionally, the increase in the inflammatory cytokine levels of TNF-α and IL-1β was inhibited and the production of IL-4 and IL-10 was promoted in the K5-EHEC group compared with the model group. B. longum K5 significantly prevented the reduction in the abundance and diversity of mouse gut microorganisms induced by EHEC O157:H7 infection, including blocking the decrease in the relative abundance of Roseburia, Lactobacillus, and Oscillibacter. Meanwhile, the intervention with B. longum K5 promoted the production of acetic acid and butyric acid in the gut. This study provides insights into the use of B. longum K5 for developing probiotic formulations to prevent intestinal diseases caused by pathogenic bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin 150030, China.
- Food College, Northeast Agricultural University, Harbin 150030, China.
ORCID-Profile: Fei Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, D., Li, C., Cao, T., Lv, X., Yue, Y., Li, S., Cheng, Y., Liu, F., Huo, G., & Li, B. (2024). Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota. Nutrients. https://doi.org/10.3390/nu16081164
Vancouver
Liu D, Li C, Cao T, Lv X, Yue Y, Li S, et al. Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota. Nutrients. 2024. doi:10.3390/nu16081164
BibTeX
@article{Liu2024,
author = {Liu, Deyu and Li, Chunyan and Cao, Ting and Lv, Xiuli and Yue, Yingxue and Li, Shuang and Cheng, Yang and Liu, Fei and Huo, Guicheng and Li, Bailiang},
title = {Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16081164}
}
EUVIMED